FDA Proposes Rule Aimed at Helping to Ensure Safety and Effectiveness of Laboratory Developed Tests

For Immediate Release:
September 29, 2023

Today, the U.S. Food and Drug Administration announced a proposed rule regarding laboratory developed tests, or LDTs, which play an important role in healthcare. The rule is aimed at helping to ensure the safety and effectiveness of these tests, which are used in a growing number of health care decisions and for which concerns have been raised for many years.Continue reading

Newsweek Ranks Barrow No. 13 Globally, No. 10 Nationally for Neurosurgery

PHOENIX (Sept. 26, 2023) – Newsweek has again named Barrow Neurological Institute one of the World’s Best Specialized Hospitals for Neurosurgery.

In its third year of ranking hospitals in neurosurgery, the media company continues to recognize Barrow as No. 1 in the Southwest and No. 10 in the nation. The Institute climbed two spots globally, sitting at No. 13 for 2024. The list includes 125 hospitals total.Continue reading

Dr. Potts Goes to Washington

AZBio Board Member Dr. Steve Potts was in Washington, D.C. on  Wednesday, September 20, 2023.  He testified in the Subcommittee on Oversight and Investigations of the House Energy and Commerce Committee on how the Inflation Reduction Act’s price setting provisions are already raising the hurdles for health innovators as they race to develop new small molecule treatments and cures. Continue reading